Peritumoral macrophages recruit eosinophils to promote antitumor immune responses in breast cancer
Proceedings of the National Academy of Sciences · 23.09.2025 · 122 (38)
DOI: 10.1073/pnas.2504645122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 15.09.2025. Verfasst von Joseph Saglimbeni und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, New York University Grossman School of Medicine, New York, NY 10016. Hauptthemen laut MEDLINE: Eosinophils, Breast Neoplasms, Macrophages, Tumor-Associated Macrophages. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Chemotherapy Foundation (Chemotherapy+ Foundation), HHS | NIH | NIAID, NIAID NIH HHS.
Abstract (Originalsprache)
Breast tumors harbor dynamic microenvironments, with multiple immune cell types playing opposing roles during tumor progression and/or response to therapy. Tumor-associated macrophages promote mammary tumorigenesis, whereas the role of mammary tissue macrophages (MTMs) remains incompletely understood. High-dimensional immunostaining of murine mammary tumor progression revealed that MTMs were localized in the peritumoral stroma and associated with eosinophils, which were previously shown to facilitate antitumor T cell responses. The depletion of MTMs accelerated tumorigenesis in both spontaneous and orthotopically transplanted mammary tumor models. Upon induction of a productive antitumor response via the depletion of regulatory T cells, MTMs assumed an alternatively activated state and expressed eotaxins, thereby attracting eosinophils to peritumoral regions. MTMs expressed the receptor for the alarmin IL-33, which induced both MTM activation and eosinophil recruitment. These results suggest that MTMs can sense IL-33 and recruit eosinophils to facilitate antitumor immunity, a mechanism that may operate during tumor progression and be further enhanced during productive antitumor responses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, New York University Grossman School of Medicine, New York, NY 10016.
- Applied Bioinformatics Laboratories, New York University Grossman School of Medicine, New York, NY 10016.
- Translational Immunology Center, New York University Grossman School of Medicine, New York, NY 10016.
- Department of Pediatrics, Dr. von Hauner Children's Hospital, University Hospital, Ludwig-Maximilians-Universität München, Munich 80337, Germany.
- Department of Microbiology, New York University Grossman School of Medicine, New York, NY 10016.
- Perlmutter Cancer Center, New York University Grossman School of Medicine, New York, NY 10016.
ORCID-Profile: Eduardo Esteva, Anna Eichinger, William Huntley, Kamal M Khanna, Igor Dolgalev, Boris Reizis
Förderung
- Chemotherapy Foundation (Chemotherapy+ Foundation)
- HHS | NIH | NIAID
- NIAID NIH HHS
- HHS | NIH | NCI
- Deutsche Forschungsgemeinschaft (DFG)
- Leon Levy Foundation
Zitieren
APA
Saglimbeni, J., Esteva, E., Canales, J., Perez, O. A., Eichinger, A., Huntley, W., Khanna, K. M., Dolgalev, I., Klar, N., Adams, S., & Reizis, B. (2025). Peritumoral macrophages recruit eosinophils to promote antitumor immune responses in breast cancer. Proceedings of the National Academy of Sciences, 122(38). https://doi.org/10.1073/pnas.2504645122
Vancouver
Saglimbeni J, Esteva E, Canales J, Perez OA, Eichinger A, Huntley W, et al. Peritumoral macrophages recruit eosinophils to promote antitumor immune responses in breast cancer. Proceedings of the National Academy of Sciences. 2025;122(38). doi:10.1073/pnas.2504645122
BibTeX
@article{Saglimbeni2025,
author = {Saglimbeni, Joseph and Esteva, Eduardo and Canales, Josue and Perez, Oriana A and Eichinger, Anna and Huntley, William and Khanna, Kamal M and Dolgalev, Igor and Klar, Natalie and Adams, Sylvia and Reizis, Boris},
title = {Peritumoral macrophages recruit eosinophils to promote antitumor immune responses in breast cancer},
journal = {Proceedings of the National Academy of Sciences},
year = {2025},
volume = {122},
number = {38},
doi = {10.1073/pnas.2504645122}
}
EUVIMED